1. Home
  2. HOG vs NKTR Comparison

HOG vs NKTR Comparison

Compare HOG & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harley-Davidson Inc.

HOG

Harley-Davidson Inc.

HOLD

Current Price

$24.46

Market Cap

2.5B

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$69.79

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOG
NKTR
Founded
1903
1990
Country
United States
United States
Employees
6400
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
HOG
NKTR
Price
$24.46
$69.79
Analyst Decision
Hold
Strong Buy
Analyst Count
7
7
Target Price
$24.00
$146.67
AVG Volume (30 Days)
2.1M
1.2M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
3.05%
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$4,473,175,000.00
$307,711,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.79
N/A
P/E Ratio
$110.14
N/A
Revenue Growth
N/A
86.00
52 Week Low
$17.09
$21.02
52 Week High
$31.25
$109.00

Technical Indicators

Market Signals
Indicator
HOG
NKTR
Relative Strength Index (RSI) 47.01 60.32
Support Level $24.34 $64.30
Resistance Level $24.83 $76.67
Average True Range (ATR) 0.97 3.22
MACD -0.16 1.50
Stochastic Oscillator 18.33 89.69

Price Performance

Historical Comparison
HOG
NKTR

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: